{"id":15831,"date":"2023-08-26T12:14:51","date_gmt":"2023-08-26T10:14:51","guid":{"rendered":"https:\/\/world-heart-federation.org\/?post_type=news&p=15831"},"modified":"2023-09-15T15:30:21","modified_gmt":"2023-09-15T13:30:21","slug":"mortality-cardiovascular-disease-and-long-covid-insights-from-whf-study-presented-at-esc-congress-2023","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/mortality-cardiovascular-disease-and-long-covid-insights-from-whf-study-presented-at-esc-congress-2023\/","title":{"rendered":"Mortality, Cardiovascular Disease, and Long COVID: Insights from WHF Study Presented at ESC Congress 2023"},"content":{"rendered":"
The COVID-19 pandemic<\/a> highlighted early the critical importance of understanding the virus’s impact on various organ systems, including the heart. Early research showed that individuals with pre-existing cardiovascular conditions were at a heightened risk of severe illness and mortality from COVID-19<\/a>. However, the long-term effects of COVID-19, particularly in those who were hospitalized, have remained a subject of discussion and debate followed by investigation.<\/p>\n Insights from early data from the WHF long COVID study is unveiled at the ESC Congress during presentation of the abstract titled “Mortality, Cardiovascular Disease<\/a>, and Long COVID at 3 Months in Individuals Hospitalized with COVID-19: This study, conducted by the World Heart Federation (WHF), aims to determine short-and long-term clinical sequelae among COVID-19 hospitalized patients across 16 low-middle-,upper-middle and high-income countries.<\/p>\n Early results show that the mortality rate at 3-months post-discharge was 3.3%, considered relatively high compared to studies conducted in other high-income countries. Over a third (37%) presented with at least one persistent long COVID symptoms 3-months post-discharge. A sizeable proportion of patients reported problems in mobility, self-care, usual activities and anxiety post-discharge at 3 months.<\/p>\n